Citation Impact
Citing Papers
Global increase and geographic convergence in antibiotic consumption between 2000 and 2015
2018 Standout
Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes
2017
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Characterization of a New Metallo-β-Lactamase Gene, bla NDM-1 , and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India
2009 Standout
Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
2009 Standout
The CTX-M Conundrum: Dissemination of Plasmids and Escherichia coli Clones
2011
Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review
2012
Nosocomial Outbreak of New Delhi Metallo-β-Lactamase-1-Producing Gram-Negative Bacteria in South Africa: A Case-Control Study
2015
Carbapenemase Genes among Multidrug Resistant Gram Negative Clinical Isolates from a Tertiary Hospital in Mwanza, Tanzania
2014
Excess Deaths Associated With Tigecycline After Approval Based on Noninferiority Trials
2012
Persistence of Klebsiella pneumoniae clones with OXA-48 or NDM carbapenemases causing bacteraemias in a Riyadh hospital
2013
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Molecular mechanisms of antibiotic resistance
2014 Standout
Immunological biomarkers of tuberculosis
2011
Contemporary activity of meropenem and comparator broad-spectrum agents: MYSTIC program report from the United States component (2005)
2006
NDM-1–producing Enterobacteriaceae from South Africa: moving towards endemicity?
2014
Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan Africa
2007
Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice
2010
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
2014 Standout
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
2011 Standout
The burden of non-communicable diseases in South Africa
2009 Standout
Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
2014 Standout
Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK
2009
An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii
2007 Standout
Procalcitonin assay in systemic inflammation, infection, and sepsis: Clinical utility and limitations
2008
Community-acquired pneumonia
2003
The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria
2008
Analysis of the clinical antibacterial and antituberculosis pipeline
2018
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
2008 Standout
Microbiology and drug resistance mechanisms of fully resistant pathogens
2004
Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance
2017
Antibacterial resistance worldwide: causes, challenges and responses
2004 Standout
Antibiotic resistance and its cost: is it possible to reverse resistance?
2010 Standout
The Clinical Relevance of Plasma Protein Binding Changes
2012
Evolution of antimicrobial resistance among Enterobacteriaceae (focus on extended spectrum β-lactamases and carbapenemases)
2013
Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study
2015 Standout
Vancomycin-resistant enterococci: consequences for therapy and infection control
2005
Clinical relevance of the ESKAPE pathogens
2013
Understanding the mechanisms and drivers of antimicrobial resistance
2015 Standout
Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: special emphasis on unbound pharmacokinetics
2010
Tuberculosis control and elimination 2010–50: cure, care, and social development
2010 Standout
The β-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter
2006
Klebsiella pneumoniae Population Genomics and Antimicrobial-Resistant Clones
2016
Antibiotic resistance in the environment
2021 Standout
The antimicrobial activity of copper and copper alloys against nosocomial pathogens and Mycobacterium tuberculosis isolated from healthcare facilities in the Western Cape: an in-vitro study
2007
The role of vaccines in preventing bacterial antimicrobial resistance
2018
Silent transmission of an IS 1294b -deactivated mcr-1 gene with inducible colistin resistance
2018
Tackling antibiotic resistance: the environmental framework
2015 Standout
Implant infections: adhesion, biofilm formation and immune evasion
2018 Standout
OmpK35 and OmpK36 porin variants associated with specific sequence types ofKlebsiella pneumoniae
2013
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
2010 Standout
Calumenin, a Ca2+-binding Protein Retained in the Endoplasmic Reticulum with a Novel Carboxyl-terminal Sequence, HDEF
1997 StandoutNobel
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
The spread of CTX-M-type extended-spectrum β-lactamases
2008
Urinary tract infections: epidemiology, mechanisms of infection and treatment options
2015 Standout
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
2009 Standout
Carriage of type II toxin-antitoxin systems by the growing group of IncX plasmids
2017
The Contribution of Blood Cultures to the Clinical Management of Adult Patients Admitted to the Hospital With Community-Acquired Pneumonia
2003
Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 β-lactamases
2007
The Effects of Hypoalbuminaemia on Optimizing Antibacterial Dosing in Critically Ill Patients
2010
Apoptosis in the Failing Human Heart
1997 Standout
Evidence for Soft Selective Sweeps in the Evolution of Pneumococcal Multidrug Resistance and Vaccine Escape
2014
The antimicrobial activity of nanoparticles: present situation and prospects for the future
2017 Standout
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
2019 Standout
Resistance to Macrolides and Related Antibiotics in Streptococcus pneumoniae
2002
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Carbapenemase-Producing Enterobacteriaceae : now that the Storm is Finally here, how will Timely Detection help us Fight Back?
2012
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
The Role of Epidemic Resistance Plasmids and International High-Risk Clones in the Spread of Multidrug-Resistant Enterobacteriaceae
2015
Mobile Genetic Elements Associated with Antimicrobial Resistance
2018 Standout
23S rRNA base pair 2057–2611 determines ketolide susceptibility and fitness cost of the macrolide resistance mutation 2058A→G
2005 StandoutNobel
Heterogeneous Macrolide Resistance and Gene Conversion in the Pneumococcus
2005
23S rRNA 2058A→G Alteration Mediates Ketolide Resistance in Combination with Deletion in L22
2006 StandoutNobel
Carbapenemases: the Versatile β-Lactamases
2007 Standout
Mechanisms of Resistance to Macrolides and Lincosamides: Nature of the Resistance Elements and Their Clinical Implications
2002
Antibiotics for community-acquired pneumonia in adult outpatients
2014
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Gene for Progressive Familial Heart Block Type I Maps to Chromosome 19q13
1995
Antibiotic Use in Agriculture and Its Consequential Resistance in Environmental Sources: Potential Public Health Implications
2018 Standout
AmpC β-Lactamases
2009 Standout
A Review of Ten Years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011
2013
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
2005 Standout
Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins
2014 Standout
Klebsiella pneumoniaeST307 withblaOXA-181,South Africa, 2014–2016
2019
First Report of OXA-181-Producing Escherichia coli in China and Characterization of the Isolate Using Whole-Genome Sequencing
2015
Sudden Cardiac Death
1998 Standout
Three Decades of β-Lactamase Inhibitors
2010 Standout
Metabolism of the heart in health and disease. Part III
1969
The Immune Response in Tuberculosis
2013 Standout
Metallic Copper as an Antimicrobial Surface
2010 Standout
Outbreak Caused by an Ertapenem-Resistant, CTX-M-15-Producing Klebsiella pneumoniae Sequence Type 101 Clone Carrying an OmpK36 Porin Variant
2013
Apoptosis as a Possible Cause of Gradual Development of Complete Heart Block and Fatal Arrhythmias Associated With Absence of the AV Node, Sinus Node, and Internodal Pathways
1996
Genomic and Transcriptomic Analyses of Colistin-Resistant Clinical Isolates of Klebsiella pneumoniae Reveal Multiple Pathways of Resistance
2014
Protein Binding of β-Lactam Antibiotics in Critically Ill Patients: Can We Successfully Predict Unbound Concentrations?
2013
CTX-M-type β-lactamases: A successful story of antibiotic resistance
2013
MgrB Inactivation Is a Common Mechanism of Colistin Resistance in KPC-Producing Klebsiella pneumoniae of Clinical Origin
2014
Therapeutic drug monitoring of antimicrobials
2011
The Lancet Infectious Diseases Commission on antimicrobial resistance: 6 years later
2020
Synthetic Riboswitches That Induce Gene Expression in Diverse Bacterial Species
2010 StandoutNobel
The Global Ascendency of OXA-48-Type Carbapenemases
2019
Origins and Evolution of Antibiotic Resistance
2010 Standout
Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing
2020 Standout
In Vitro Study of IS Apl1 -Mediated Mobilization of the Colistin Resistance Gene mcr-1
2017
The global epidemiology of carbapenemase-producing Enterobacteriaceae
2016 Standout
Enterobacter cloacae Complex: Clinical Impact and Emerging Antibiotic Resistance
2012
Emergence of carbapenem-resistant clinical Enterobacteriaceae isolates from a teaching hospital in Shanghai, China
2011
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
A Model for Transposition of the Colistin Resistance Gene mcr-1 by IS Apl1
2016
Global spread of antibiotic resistance: the example of New Delhi metallo-β-lactamase (NDM)-mediated carbapenem resistance
2013
Locally Acquired mcr-1 in Escherichia coli, Australia, 2011 and 2013
2017
Works of Adrian Brink being referenced
Appropriate use of the carbapenems.
2004
Antimicrobial Susceptibility of Gram-Negative Pathogens Isolated from Patients with Complicated Intra-Abdominal Infections in South African Hospitals (SMART Study 2004–2009): Impact of the New Carbapenem Breakpoints
2012
Procalcitonin and C-reactive protein levels in HIV-positive subjects with tuberculosis and pneumonia
2005
The spread of carbapenem-resistant Enterobacteriaceae in South Africa: Risk factors for acquisition and prevention
2012
Pharmacokinetics of once-daily dosing of ertapenem in critically ill patients with severe sepsis
2008
In Vivo Development of Ertapenem Resistance in a Patient with Pneumonia Caused by Klebsiella pneumoniae with an Extended-Spectrum -Lactamase
2006
Antimicrobial stewardship across 47 South African hospitals: an implementation study
2016
Antimicrobial resistance in the next 30 years, humankind, bugs and drugs: a visionary approach
2017
Multicomponent antibiotic substances produced by fermentation: Implications for regulatory authorities, critically ill patients and generics
2013
A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail
2016
Recommendations to achieve rapid therapeutic teicoplanin plasma concentrations in adult hospitalised patients treated for sepsis
2008
Guideline: Appropriate use of tigecycline
2010
Emergence of plasmid-mediated colistin resistance (MCR-1) among Escherichia coli isolated from South African patients
2016
Emergence of New Delhi Metallo-Beta-Lactamase (NDM-1) and Klebsiella pneumoniae Carbapenemase (KPC-2) in South Africa
2011
Epidemiology of Glycopeptide-Resistant Enterococci Colonizing High-Risk Patients in Hospitals in Johannesburg, Republic of South Africa
2000
Resistance to Colistin Associated with a Single Amino Acid Change in Protein PmrB among Klebsiella pneumoniae Isolates of Worldwide Origin
2014
Hereditary dysrhythmic congestive cardiomyopathy.
1976
Emergence of extensive drug resistance (XDR) among Gram-negative bacilli in South Africa looms nearer.
2008
Management of community-acquired pneumonia in adults
2008
Part V. Surveillance activities.
2011
Progressive familial heart block. Part II. Clinical and ECG confirmation of progression--report on 4 cases.
1986
Antimicrobial susceptibility profile of selected bacteraemic pathogens from private institutions in South Africa.
2007
The emergence of carbapenem resistance in Enterobacteriaceae in south africa
2011
Heteroresistance to Colistin in Klebsiella pneumoniae Associated with Alterations in the PhoPQ Regulatory System
2015
Emergence of OXA-48 and OXA-181 Carbapenemases among Enterobacteriaceae in South Africa and Evidence of In Vivo Selection of Colistin Resistance as a Consequence of Selective Decontamination of the Gastrointestinal Tract
2012
Serotype 19F Multiresistant Pneumococcal Clone Harboring Two Erythromycin Resistance Determinants [ erm (B) and mef (A)] in South Africa
2001
Progressive familial heart block. Part I. Extent of the disease.
1986
Thiamine deficiency and beriberi heart disease.
1966
Genetic Features of MCR-1-Producing Colistin-Resistant Escherichia coli Isolates in South Africa
2016